Mouhammed Amir Habra Selected Research

Hepatocyte Growth Factor (Growth Factor, Hepatocyte)

10/2015

Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mouhammed Amir Habra Research Topics

Disease

33	Neoplasms (Cancer) 04/2024 - 12/2008
19	Adrenocortical Carcinoma 04/2024 - 09/2012
10	Thyroid Neoplasms (Thyroid Cancer) 01/2021 - 08/2004
7	Pheochromocytoma 08/2020 - 08/2004
6	Hypertension (High Blood Pressure) 04/2024 - 11/2012
6	Paraganglioma (Paragangliomas) 04/2024 - 11/2010
4	Neoplasm Metastasis (Metastasis) 04/2024 - 08/2004
4	Disease Progression 01/2020 - 02/2011
4	Cushing Syndrome 01/2019 - 10/2011
3	Pituitary Neoplasms (Pituitary Adenoma) 03/2018 - 10/2015
2	Adrenal Cortex Neoplasms (Adrenocortical Cancer) 01/2023 - 05/2021
2	Hypoxia (Hypoxemia) 01/2022 - 11/2010
2	Microsatellite Instability 01/2022 - 01/2019
2	Margins of Excision 01/2022 - 02/2020
2	Adrenal Gland Neoplasms (Adrenal Cancer) 05/2021 - 03/2014
2	Fatigue 01/2021 - 02/2015
2	Hypothyroidism 01/2021 - 01/2016
1	Hypophosphatemia 04/2024
1	Rectal Fistula (Anal Fistula) 04/2024
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 08/2022
1	Hematologic Neoplasms (Hematological Malignancy) 05/2021
1	Headache (Headaches) 01/2021
1	Hypophysitis 01/2021
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 10/2020
1	Kidney Neoplasms (Kidney Cancer) 01/2020
1	Carcinoma (Carcinomatosis) 01/2020
1	Hyperplasia 01/2020
1	Anaplastic Thyroid Carcinoma 11/2018
1	Exanthema (Rash) 11/2018
1	Adrenocortical Adenoma (Disease, Conn's) 03/2018
1	Carcinoid Tumor (Carcinoid) 07/2017
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 07/2017
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 07/2017
1	Pituitary ACTH Hypersecretion 07/2017
1	Spontaneous Fractures (Pathological Fracture) 12/2016
1	Ectopic ACTH Syndrome 10/2015

Drug/Important Bio-Agent (IBA)

6	lenvatinibIBA 01/2021 - 02/2015
6	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2021 - 10/2011
5	pembrolizumabIBA 08/2020 - 11/2018
4	cabozantinibIBA 04/2024 - 01/2016
4	Mitotane (Lysodren)FDA Link 04/2024 - 01/2013
4	Tyrosine Kinase InhibitorsIBA 01/2016 - 05/2013
3	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2024 - 07/2017
3	Hormones (Hormone)IBA 08/2022 - 05/2021
3	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2020
3	CatecholaminesIBA 08/2020 - 11/2010
3	Sorafenib (BAY 43-9006)FDA Link 01/2020 - 05/2013
3	Biomarkers (Surrogate Marker)IBA 03/2018 - 01/2017
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2018 - 01/2014
2	Antineoplastic Agents (Antineoplastics)IBA 04/2024 - 05/2021
2	Antihypertensive Agents (Antihypertensives)IBA 04/2024 - 11/2012
2	Lipase (Acid Lipase)FDA Link 04/2024 - 04/2024
2	PlatinumIBA 10/2021 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2017
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2018 - 02/2015
2	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 01/2017 - 02/2011
2	IodineIBA 01/2016 - 01/2014
2	Glucose (Dextrose)FDA LinkGeneric 11/2012 - 02/2010
2	Codon (Codons)IBA 02/2011 - 08/2004
1	TransferasesIBA 04/2024
1	Amylases FDA Link 04/2024
1	Alanine Transaminase (SGPT)IBA 04/2024
1	AndrogensIBA 01/2024
1	Etoposide (VP 16)FDA LinkGeneric 01/2023
1	Cisplatin (Platino)FDA LinkGeneric 01/2023
1	Capsules (Microcapsules)IBA 08/2022
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2022
1	Insulin-Like PeptidesIBA 05/2021
1	Cytotoxins (Cytolysins)IBA 05/2021
1	Monoclonal AntibodiesIBA 05/2021
1	ExotoxinsIBA 05/2021
1	VaccinesIBA 05/2021
1	figitumumabIBA 05/2021
1	cixutumumabIBA 05/2021
1	GlucocorticoidsIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	relacorilantIBA 01/2021
1	sterol O-acyltransferase 1IBA 10/2020
1	nevanimibeIBA 10/2020
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2020
1	LigandsIBA 11/2018
1	Phosphotransferases (Kinase)IBA 11/2018
1	Apoptosis Regulatory ProteinsIBA 11/2018
1	2,4,5-trimethoxyphenylisopropylamine (TMA-2)IBA 03/2018
1	Proteins (Proteins, Gene)FDA Link 03/2018
1	Nuclear Proteins (Protein, Nuclear)IBA 03/2018
1	Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA 01/2018
1	P-2 (P 2)IBA 01/2018
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 01/2018
1	Cell-Free Nucleic AcidsIBA 01/2017
1	vandetanib (ZD6474)IBA 01/2016
1	Small Interfering RNA (siRNA)IBA 10/2015
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 10/2015

Therapy/Procedure

18	Therapeutics 04/2024 - 02/2010
8	Drug Therapy (Chemotherapy) 04/2024 - 08/2013
4	Immunotherapy 01/2022 - 06/2017
3	Radiotherapy 02/2020 - 08/2004
2	Cytoreduction Surgical Procedures 01/2022 - 01/2022
2	Salvage Therapy 01/2020 - 01/2019
2	Adjuvant Radiotherapy 01/2013 - 08/2004